When the expression of lncRNA-TINCR is decreased in metastatic melanoma, its downregulation promotes the expression level of proliferation-, migration- and invasion-related marker genes and increases its resistance to drugs such as BRAF and MEK inhibitors in melanoma progression (80). Here, MAP2K7 is linked to melanoma.